Found: 8
Select item for more details and to access through your institution.
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00240-0
- By:
- Publication type:
- Article
Fusion of HCV Nonstructural Antigen to MHC Class II-associated Invariant Chain Enhances T-cell Responses Induced by Vectored Vaccines in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 5, p. 1039, doi. 10.1038/mt.2014.15
- By:
- Publication type:
- Article
MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 548, p. 1, doi. 10.1126/scitranslmed.aaz7715
- By:
- Publication type:
- Article
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2018.03175
- By:
- Publication type:
- Article
Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101591
- By:
- Publication type:
- Article
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 300, p. 1, doi. 10.1126/scitranslmed.aac5745
- By:
- Publication type:
- Article
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3009185
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
- Published in:
- 2019
- By:
- Publication type:
- journal article